Cargando…

A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases

Cardiovascular diseases (CVDs) continue to be the leading cause of health problems around the world. Because of its unique properties, reactive oxygen species (ROS)-based nanotechnology offers novel solutions to the diagnosis and treatment of CVDs. In order to identify and further promote the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yun, Liao, Shenjie, Zhang, Xiaoshen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294284/
https://www.ncbi.nlm.nih.gov/pubmed/35865387
http://dx.doi.org/10.3389/fcvm.2022.940769
_version_ 1784749817079005184
author Liang, Yun
Liao, Shenjie
Zhang, Xiaoshen
author_facet Liang, Yun
Liao, Shenjie
Zhang, Xiaoshen
author_sort Liang, Yun
collection PubMed
description Cardiovascular diseases (CVDs) continue to be the leading cause of health problems around the world. Because of its unique properties, reactive oxygen species (ROS)-based nanotechnology offers novel solutions to the diagnosis and treatment of CVDs. In order to identify and further promote the development of ROS-based nanotechnology in CVDs, we here provide a bibliometric analysis. 701 eligible articles about the ROS–based nanotechnology for CVD up to May 26th, 2022, were taken from the Web of Science Core Collection database. The VOSviewer was used to analyze annual publications, countries/institutions, funding agencies, journals and research category, and the research hotspots. From the publication of the first article in 2005 to 2021, the output and the number of citations of articles are on the rise. Based on the bibliometric analysis, we found that the current research focuses on the correlation between diagnosis (sensors and), treatment (oxidative stress, inflammation, and drug delivery) and safety (toxicity). Since 2019, research on nanomedicine and drug delivery has become a hotspot. So, more research in chemistry, materials, biology, and medicine is required to further develop and construct ROS-based nanomaterials.
format Online
Article
Text
id pubmed-9294284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92942842022-07-20 A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases Liang, Yun Liao, Shenjie Zhang, Xiaoshen Front Cardiovasc Med Cardiovascular Medicine Cardiovascular diseases (CVDs) continue to be the leading cause of health problems around the world. Because of its unique properties, reactive oxygen species (ROS)-based nanotechnology offers novel solutions to the diagnosis and treatment of CVDs. In order to identify and further promote the development of ROS-based nanotechnology in CVDs, we here provide a bibliometric analysis. 701 eligible articles about the ROS–based nanotechnology for CVD up to May 26th, 2022, were taken from the Web of Science Core Collection database. The VOSviewer was used to analyze annual publications, countries/institutions, funding agencies, journals and research category, and the research hotspots. From the publication of the first article in 2005 to 2021, the output and the number of citations of articles are on the rise. Based on the bibliometric analysis, we found that the current research focuses on the correlation between diagnosis (sensors and), treatment (oxidative stress, inflammation, and drug delivery) and safety (toxicity). Since 2019, research on nanomedicine and drug delivery has become a hotspot. So, more research in chemistry, materials, biology, and medicine is required to further develop and construct ROS-based nanomaterials. Frontiers Media S.A. 2022-07-05 /pmc/articles/PMC9294284/ /pubmed/35865387 http://dx.doi.org/10.3389/fcvm.2022.940769 Text en Copyright © 2022 Liang, Liao and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Liang, Yun
Liao, Shenjie
Zhang, Xiaoshen
A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title_full A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title_fullStr A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title_full_unstemmed A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title_short A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
title_sort bibliometric analysis of reactive oxygen species based nanotechnology for cardiovascular diseases
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294284/
https://www.ncbi.nlm.nih.gov/pubmed/35865387
http://dx.doi.org/10.3389/fcvm.2022.940769
work_keys_str_mv AT liangyun abibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases
AT liaoshenjie abibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases
AT zhangxiaoshen abibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases
AT liangyun bibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases
AT liaoshenjie bibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases
AT zhangxiaoshen bibliometricanalysisofreactiveoxygenspeciesbasednanotechnologyforcardiovasculardiseases